Bone mineral density response to romosozumab in post-menopausal women: A prospective observational real-world study
Baseline BMD was associated with total hip BMD response to romosozumab. Age itself was not associated with BMD differences. Our data support the effectiveness of romosozumab in older postmenopausal women in routine clinical practice.
Authors
- Jolan Dupont (ORCID: https://orcid.org/0000-0001-5336-2791)
- Ombretta Viapiana (ORCID: https://orcid.org/0000-0003-1917-5655)
- Nadjia Amini (ORCID: https://orcid.org/0000-0003-1164-2896)
- Michaël R. Laurent (ORCID: https://orcid.org/0000-0001-9681-8330)
- Giovanni Adami (ORCID: https://orcid.org/0000-0002-8915-0755)
- Matteo Rossini (ORCID: https://orcid.org/0000-0002-5233-5836)
- Marian Dejaeger (ORCID: https://orcid.org/0000-0002-7289-1397)
- Evelien Gielen (ORCID: https://orcid.org/0000-0002-8985-1201)
- Kurt de Vlam (ORCID: https://orcid.org/0000-0003-3848-5122)
- D. Coppens
Institutions
- University of Verona (IT)
- Imelda Hospital (BE)
- Department of Public Health (US)
- KU Leuven (BE)
Publication Details
- Journal
- Bone
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.bone.2025.117701
- Citations
- 1
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 1.72